LUSSANA FEDERICO

Didattica

A.A.: 2020/2021

A.A.: 2019/2020

Pubblicazioni

  • Salmoiraghi, S., Cavagna, R., Zanghì, P., Pavoni, C., Michelato, A., Buklijas, K., et al. (2020). High throughput molecular characterization of normal karyotype acute myeloid leukemia in the context of the prospective trial 02/06 of the northern italy leukemia group (NILG). CANCERS, 12(8), 1-14. Dettaglio
  • Caprioli, C., Lussana, F., Salmoiraghi, S., Cavagna, R., Buklijas, K., Elidi, L., et al. (2020). Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06. HAEMATOLOGICA. Dettaglio
  • Magnani, C., Gaipa, G., Lussana, F., Belotti, D., Gritti, G., Napolitano, S., et al. (2020). Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities. THE JOURNAL OF CLINICAL INVESTIGATION, 130(11), 6021-6033. Dettaglio